Novel inhaled respiratory medicine development pipeline
Pulmocide is generating a pipeline of novel, potent first-in-class anti-infective agents for delivery by inhaled administration for the treatment of life-threatening lower respiratory tract viral and fungal infections.
Overview of Pipeline
Act quickly and precisely (cf systemic), lower-dose required
Neutralize infection quickly, fewer (and less severe) unwanted effects
Sustained action and minimal emergence of resistance